Today: 1 May 2026
Browse Category

NYSE:UNH 15 January 2026 - 25 January 2026

Healthcare stocks brace for a key week: XLV slips as Wegovy pill data and UnitedHealth earnings loom

Healthcare stocks brace for a key week: XLV slips as Wegovy pill data and UnitedHealth earnings loom

The Health Care Select Sector SPDR Fund (XLV) fell 0.5% to $157.48 Friday, with Eli Lilly down 2.1%. Johnson & Johnson and UnitedHealth posted small gains. Traders are watching obesity-drug demand and a crowded earnings calendar next week. The FDA linked ByHeart’s recalled infant formula to a multi-state botulism outbreak.
25 January 2026
·····
Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

XLV fell 0.51% to $157.48 Friday, trailing the S&P 500, which ended flat. Health insurer CEOs faced House scrutiny over rising premiums and consolidation, with UnitedHealth pledging ACA rebates in 2026. UnitedHealth reports earnings Jan. 27, Regeneron on Jan. 30. Corcept Therapeutics jumped 45% after positive ovarian cancer trial results.
24 January 2026
·····
UnitedHealth stock price edges up after-hours as ACA rebate pledge keeps UNH in focus

UnitedHealth stock price edges up after-hours as ACA rebate pledge keeps UNH in focus

UnitedHealth shares rose about 0.5% in after-hours trading Friday, closing at $356.26. The move followed CEO Stephen Hemsley’s announcement that the company will rebate profits from its Obamacare plans as Congress scrutinizes insurer practices. Lawmakers questioned UnitedHealth and other major insurers on Capitol Hill over rising costs. Investors await UnitedHealth’s earnings report and 2026 guidance on Jan. 27.
24 January 2026
·
UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth shares rose 0.2% to $355.19 in late morning trading Friday after the company pledged to rebate ACA marketplace profits in 2026. The move follows a contentious Capitol Hill hearing on insurer competition and rising premiums. Investors await UnitedHealth’s January 27 earnings and 2026 outlook for signals on medical costs.
23 January 2026
··
Why UnitedHealth Group (UNH) stock rose today as Obamacare rebates and earnings loom

Why UnitedHealth Group (UNH) stock rose today as Obamacare rebates and earnings loom

UnitedHealth shares rose 1.96% to $354.47 Thursday as investors focused on the insurer’s plan to rebate ACA profits starting in 2026. CEO Stephen Hemsley faced lawmakers over rising insurance costs, while analysts await the company’s Jan. 27 results and 2026 outlook. ACA premiums are projected to more than double next year, with enrollment expected to fall by two-thirds.
22 January 2026
··
Dow Jones rebounds as Trump rules out force on Greenland; tariffs still hang over Wall Street

Dow Jones rebounds as Trump rules out force on Greenland; tariffs still hang over Wall Street

The Dow Jones rose about 0.6% Wednesday, recovering nearly 297 points after President Trump ruled out using force to acquire Greenland. Tuesday saw the index plunge 870 points following new U.S. tariffs on European goods. Merck and UnitedHealth led early gains, while IBM and 3M dragged on the previous session. Investors await jobless claims data Thursday and the Fed meeting next week.
21 January 2026
······
Dow Jones rebounds after Tuesday’s 870-point hit as Trump cools Greenland talk

Dow Jones rebounds after Tuesday’s 870-point hit as Trump cools Greenland talk

The Dow Jones rose 203 points to 48,692.15 early Wednesday, rebounding after Tuesday’s 870-point drop triggered by Trump’s tariff threats on eight European countries. Healthcare stocks led gains, with Merck and UnitedHealth adding about 40 points. The Supreme Court began hearing arguments on Trump’s bid to fire Fed Governor Lisa Cook. A Reuters poll showed economists expect the Fed to hold rates steady this quarter.
21 January 2026
·······
UnitedHealth stock back in focus: Bernstein sticks with $444 target as UNH earnings near

UnitedHealth stock back in focus: Bernstein sticks with $444 target as UNH earnings near

UnitedHealth shares closed down 2.3% at $331.02 Friday as Bernstein reiterated an Outperform rating and $444 target, citing potential margin recovery in Medicare Advantage and Medicaid. The company reports earnings and 2026 guidance Jan. 27, with investors focused on medical costs and outlook. U.S. lawmakers will question UnitedHealth’s CEO Jan. 22 on coverage affordability. Markets reopen Tuesday after the holiday.
19 January 2026
··
UnitedHealth stock slips into the holiday pause: what UNH investors watch before Jan. 27 guidance

UnitedHealth stock slips into the holiday pause: what UNH investors watch before Jan. 27 guidance

UnitedHealth shares dropped 2.3% to $331.02 Friday, leading healthcare declines before the Martin Luther King Jr. Day market closure. The company faces scrutiny after a Senate report accused it of inflating Medicare Advantage payments, which UnitedHealth denies. Investors await its 2025 results and 2026 guidance, due Jan. 27. A possible sale of Optum UK to TPG remains under negotiation.
18 January 2026
·
Why UnitedHealth stock fell today: UNH slides as Medicare Advantage spotlight returns

Why UnitedHealth stock fell today: UNH slides as Medicare Advantage spotlight returns

UnitedHealth shares fell 2.3% to $331.02 in after-hours trading Friday following a MedPAC report highlighting $76 billion in projected Medicare Advantage overpayments. The drop came ahead of a long holiday weekend and the company’s earnings release set for Jan. 27. Managed-care stocks broadly declined, with Humana down 3.76% and Elevance Health off 1.85%.
17 January 2026
···
UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth shares fell 1.3% to $334.40 Friday, weighing on the Dow as managed-care stocks slid after Trump’s new healthcare proposal. The plan, which would replace insurance subsidies with direct payments to consumers, left policy details unclear and insurers under pressure. UnitedHealth will report 2025 earnings and its 2026 outlook on Jan. 27. Investors are watching for updates on government-plan costs and future guidance.
16 January 2026
······
Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

The Dow Jones Industrial Average fell 70 points, or 0.14%, to 49,372.07 in early Friday trading as losses in healthcare and consumer stocks offset gains in tech. The S&P 500 edged up 0.07%, while the Nasdaq rose 0.26%. PNC Financial jumped 3.9% after reporting a 25% profit increase. Options expiration and muted volatility kept traders cautious near record highs.
16 January 2026
········
UnitedHealth stock climbs as UnitedHealthcare rolls out fast-pay Medicare Advantage pilot for rural hospitals

UnitedHealth stock climbs as UnitedHealthcare rolls out fast-pay Medicare Advantage pilot for rural hospitals

UnitedHealth shares rose 1.2% to $338.96 after launching a six-month pilot to speed up Medicare Advantage payments to rural hospitals in four states. The initiative aims to cut collection times to under 15 days. Investors await UnitedHealth’s 2025 earnings and 2026 forecast, due Jan. 27. The company faces scrutiny after a Senate report accused it of aggressive coding practices, which UnitedHealth disputes.
16 January 2026
·
UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

UnitedHealth shares rose 0.7% to $337.27 after rebounding from a 2% drop Thursday. The move followed UnitedHealthcare’s launch of a six-month pilot to speed Medicare Advantage payments for rural hospitals in four states. Investors are focused on the company’s Jan. 27 earnings and 2026 outlook. Rural providers face financial strains as federal budget changes loom.
15 January 2026
··
1 2 3 4 5 6 … 9

Stock Market Today

  • Duolingo (DUOL) Share Price Plunges Despite Undervaluation Indicated by Cash Flow Analysis
    April 30, 2026, 10:34 PM EDT. Duolingo's shares have fallen 72.5% over the past year, dragging its stock price to $110.10, a 37.6% year-to-date decline amid shifting digital education trends. Despite this, a Discounted Cash Flow (DCF) model suggests the stock is undervalued by 53.1%, with a projected intrinsic value of $234.97 per share based on future free cash flow projections. The company reported $360 million in free cash flow over the last twelve months, with expectations rising to $538 million by 2035. While Duolingo's price reflects short-term challenges, its long-term potential remains attractive according to valuation metrics. Investors may want to reassess the stock given its recent pullback and fundamental outlook.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
Go toTop